Slings, botulinum toxin among key female urology topics
In the area of female urology, look for key studies at the AUA annual meeting involving sling surgery, onabotulinumtoxinA (Botox) injections, and reoperation after pelvic organ prolapse surgery with mesh.
This article is part of the State of Urology 2013
In the area of female urology, look for key studies at the AUA annual meeting involving sling surgery, onabotulinumtoxinA (Botox) injections, and reoperation after pelvic organ prolapse surgery with mesh.
Specifically, here are 10 can’t-miss abstracts on female urology from this year’s meeting, as selected by Shlomo Raz, MD, of UCLA:
559: Repeat Post-Op Voiding Trials: An Inconvenient Correlate with Success
Kimberly Ferrante
560: Incontinence Symptoms Following Suburethral Sling Removal
Leah Nakamura
561: Management of recurrent stress urinary incontinence after SISTER and TOMUS procedures
Philippe Zimmerman
1040: Worsening urinary storage symptoms following sling surgery in stress-incontinent women: incidence, associations, and management
Joshua P. Holstead
1359: Deterioration of continence after TOT when the follow-up is extended: results from a randomised controlled study
Elisabetta Costantini
1370: Tined lead versus percutaneous nerve evaluation for sacral nerve stimulator assessment
Julie Jenks
1717: Consistent and Persistent Long-term Efficacy After Repeat OnabotulinumtoxinA Detrusor Injections in Patients with Neurogenic Detrusor Overactivity
Michael Kennelly
1955: Comparison of baseline urologic symptoms in men and women with interstitial cystitis/bladder pain syndrome or chronic prostatitis/chronic pelvic pain syndrome
J. Quentin Clemens
2144: Colpocleisis: A Safe, Minimally Invasive Option for Treating Prolapse
Margaret Mueller
2148: Reoperation For Any Reason After Pelvic Organ Prolapse Surgery With Mesh
Jamie M. Bartley
Destigmatizing Urology: Dr. Winter discusses STDs/STIs
March 22nd 2022“We need to just approach STIs as the medical conditions they are because until we do, and until we take those stigmas away, people will truly have resistance to discussing it, hesitance to discussing it, and resistance to diagnosis and intervention,” says Ashley Winter, MD.
